| Final analysis of DeCOG-SLT trial: no survival benefit for complete lymph node dissection in patients with melanoma with positive sentinel node U Leiter, R Stadler, C Mauch, W Hohenberger, NH Brockmeyer, C Berking, ... Journal of Clinical Oncology 37 (32), 3000-3008, 2019 | 200 | 2019 |
| Management of hepatic angiomyolipoma: a systematic review AJ Klompenhouwer, D Verver, S Janki, WM Bramer, M Doukas, ... Liver International 37 (9), 1272-1280, 2017 | 83 | 2017 |
| Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations D Verver, D van Klaveren, ACJ van Akkooi, P Rutkowski, BWEM Powell, ... European Journal of Cancer 96, 25-33, 2018 | 74 | 2018 |
| Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes D Verver, D van Klaveren, V Franke, ACJ van Akkooi, P Rutkowski, ... Journal of British Surgery 106 (3), 217-225, 2019 | 37 | 2019 |
| Near-infrared fluorescence imaging compared to standard sentinel lymph node detection with blue dye in patients with vulvar cancer–a randomized controlled trial MM Deken, HC van Doorn, D Verver, LSF Boogerd, KS de Valk, ... Gynecologic Oncology 159 (3), 672-680, 2020 | 33 | 2020 |
| Treatment of melanoma of unknown primary in the era of immunotherapy and targeted therapy: A Dutch population‐based study D Verver, AAM van der Veldt, ACJ van Akkooi, C Verhoef, DJ Grünhagen, ... International Journal of Cancer 146 (1), 26-34, 2020 | 32 | 2020 |
| Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma E Mulder, JT Dwarkasing, D Tempel, A van der Spek, L Bosman, D Verver, ... British Journal of Dermatology 184 (5), 944-951, 2021 | 31 | 2021 |
| Vascular management during live donor nephrectomy: an online survey among transplant surgeons S Janki, D Verver, KWJ Klop, AL Friedman, TG Peters, LE Ratner, ... American Journal of Transplantation 15 (6), 1701-1707, 2015 | 31 | 2015 |
| Treatment of extra-articular proximal and middle phalangeal fractures of the hand: a systematic review D Verver, L Timmermans, RA Klaassen, CH Van der Vlies, DI Vos, ... Strategies in trauma and limb reconstruction 12, 63-76, 2017 | 30 | 2017 |
| Improved stratification of pT1 melanoma according to the 8th American Joint Committee on Cancer staging edition criteria: a Dutch population-based study D Verver, WJ Louwman, S Koljenović, C Verhoef, DJ Grünhagen, ... European Journal of Cancer 92, 100-107, 2018 | 14 | 2018 |
| The EORTC-DeCOG nomogram adequately predicts outcomes of patients with sentinel node–positive melanoma without the need for completion lymph node dissection D Verver, A Rekkas, C Garbe, D van Klaveren, ACJ van Akkooi, ... European Journal of Cancer 134, 9-18, 2020 | 12 | 2020 |
| Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I–II melanoma patients at risk of disease relapse EEAP Mulder, I Johansson, DJ Grünhagen, D Tempel, ... Cancers 14 (12), 2854, 2022 | 11 | 2022 |
| Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin D Verver, MF Madu, CMC Oude Ophuis, M Faut, JHW de Wilt, ... Journal of British Surgery 105 (1), 96-105, 2018 | 11 | 2018 |
| Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy D Verver, DJ Grünhagen, ACJ van Akkooi, MJB Aarts, ... Cancer Immunology, Immunotherapy, 1-13, 2021 | 9 | 2021 |
| Validation of a clinicopathological and gene expression profile (CP-GEP) model for sentinel lymph node metastasis in primary cutaneous melanoma E Mulder, JT Dwarkasing, LM Hollestein, D Tempel, L Bosman, D Verver, ... Annals of Oncology 30, v540, 2019 | 8 | 2019 |
| Gamma probe and ultrasound-guided fine needle aspiration cytology of the sentinel node (GULF) trial D Verver, CMC Oude Ophuis, LB Koppert, C De Monyé, ... European journal of nuclear medicine and molecular imaging 45, 1926-1933, 2018 | 7 | 2018 |
| Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas D Verver, V Poirier-Colame, G Tomasic, K Cherif-Rebai, DJ Grunhagen, ... OncoImmunology 8 (11), e1660121, 2019 | 4 | 2019 |
| Treatment of clinical T1 rectal cancer in the Netherlands; a population-based overview of clinical practice M Verseveld, D Verver, BJ Noordman, S Pouwels, MAG Elferink, ... European Journal of Surgical Oncology 48 (5), 1153-1160, 2022 | 2 | 2022 |
| ‘Toezicht op zorgnetwerken van thuiswonende kwetsbare ouderen’Fase I en II D Verver, H Merten, C Wagner EMGO Institute for Health and Care Research, 2015 | 2 | 2015 |
| Implementation of vacuum-assisted excision as a management option for benign and high-risk breast lesions EMF van de Voort, GM Struik, E Birnie, RHJA Sinke, D Verver, ... The British Journal of Radiology 96 (1147), 20220776, 2023 | 1 | 2023 |
